Viewing Study NCT00540592


Ignite Creation Date: 2025-12-24 @ 3:43 PM
Ignite Modification Date: 2026-02-21 @ 1:12 AM
Study NCT ID: NCT00540592
Status: COMPLETED
Last Update Posted: 2018-06-08
First Post: 2007-10-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Immunogenicity and Safety Study to Evaluate Different Formulations of GSK Biologicals' Influenza Vaccine GSK576389A
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Influenza View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Influenza infection View
None Fluarix View
None Influenza vaccine GSK576389A View